HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Synthesis and SAR of 4-aminocyclopentapyrrolidines as orally active N-type calcium channel inhibitors for inflammatory and neuropathic pain.

Abstract
A novel series of N-type calcium channel inhibitors have been discovered. Optimization of potency and HT-ADME properties provides 4-aminocyclopentapyrrolidines with analgesic efficacy after oral dosing.
AuthorsXenia Beebe, Clinton M Yeung, Daria Darczak, Shashank Shekhar, Timothy A Vortherms, Loan Miller, Ivan Milicic, Andrew M Swensen, Chang Z Zhu, Patricia Banfor, Jill M Wetter, Kennan C Marsh, Michael F Jarvis, Victoria E Scott, Michael R Schrimpf, Chih-Hung Lee
JournalBioorganic & medicinal chemistry letters (Bioorg Med Chem Lett) Vol. 23 Issue 17 Pg. 4857-61 (Sep 01 2013) ISSN: 1464-3405 [Electronic] England
PMID23876987 (Publication Type: Journal Article)
CopyrightCopyright © 2013 Elsevier Ltd. All rights reserved.
Chemical References
  • Analgesics
  • Calcium Channel Blockers
  • Calcium Channels, N-Type
Topics
  • Administration, Oral
  • Analgesics (chemical synthesis, chemistry, metabolism, therapeutic use)
  • Animals
  • Calcium Channel Blockers (chemical synthesis, chemistry, metabolism, therapeutic use)
  • Calcium Channels, N-Type (metabolism)
  • Humans
  • Microsomes (metabolism)
  • Neuralgia (drug therapy)
  • Rats
  • Structure-Activity Relationship

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: